Search Results - Jerome Galon

Jérôme Galon

Jérôme Galon is a French biologist. He is Director of Research of Exceptional Class (DRCE) at ''Institut National de la Santé et de la Recherche Médicale'' (INSERM). He is also an entrepreneur and co-founder of HalioDx. Provided by Wikipedia
Refine Results
  1. 1
    Principles of risk assessment in colon cancer: immunity is key

    Principles of risk assessment in colon cancer: immunity is key by Assia Hijazi, Jérôme Galon

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Immune sunrise: from the immunome to the cancer immune landscape

    Immune sunrise: from the immunome to the cancer immune landscape by Gabriela Bindea, Bernhard Mlecnik, Jérôme Galon

    Published 2022-12-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Tumor spread or siege immunity: dissemination to distant metastasis or not

    Tumor spread or siege immunity: dissemination to distant metastasis or not by Gabriela Bindea, Bernhard Mlecnik, Jérôme Galon

    Published 2021-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Evasion before invasion: Pre-cancer immunosurveillance

    Evasion before invasion: Pre-cancer immunosurveillance by Mihaela Angelova, Céline Mascaux, Jérôme Galon

    Published 2021-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Expand to shield: IL-15 and in situ lymphocytic proliferation

    Expand to shield: IL-15 and in situ lymphocytic proliferation by Gabriela Bindea, Bernhard Mlecnik, Jérôme Galon

    Published 2021-01-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Usefulness and robustness of Immunoscore for personalized management of cancer patients

    Usefulness and robustness of Immunoscore for personalized management of cancer patients by Florence Marliot, Franck Pagès, Jérôme Galon

    Published 2020-01-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Light on life: immunoscore immune-checkpoint, a predictor of immunotherapy response

    Light on life: immunoscore immune-checkpoint, a predictor of immunotherapy response by Assia Hijazi, Carlotta Antoniotti, Chiara Cremolini, Jérôme Galon

    Published 2023-12-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    License to kill: microsatellite instability and immune contexture

    License to kill: microsatellite instability and immune contexture by Pauline Maby, Gabriela Bindea, Bernhard Mlecnik, Jérôme Galon

    Published 2021-01-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    The consensus Immunoscore in phase 3 clinical trials; potential impact on patient management decisions

    The consensus Immunoscore in phase 3 clinical trials; potential impact on patient management decisions by Franck Pagès, Julien Taieb, Pierre Laurent-Puig, Jérôme Galon

    Published 2020-01-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    The consensus immunoscore: toward a new classification of colorectal cancer

    The consensus immunoscore: toward a new classification of colorectal cancer by Anastasia Lanzi, Franck Pagès, Christine Lagorce-Pagès, Jérôme Galon

    Published 2020-01-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Precision immunity: Immunoscore and neoadjuvant treatment in bladder cancer

    Precision immunity: Immunoscore and neoadjuvant treatment in bladder cancer by Elise F. Nassif, Constance Thibault, Stéphane Oudard, Jérôme Galon

    Published 2021-01-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Multiverse of immune microenvironment in metastatic colorectal cancer

    Multiverse of immune microenvironment in metastatic colorectal cancer by Marc Van den Eynde, Bernhard Mlecnik, Gabriela Bindea, Jérôme Galon

    Published 2020-01-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patients

    Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patients by Pamela Baldin, Marc Van den Eynde, Bernhard Mlecnik, Jérôme Galon

    Published 2020-01-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Metastasis immune-based scores predict patient survival

    Metastasis immune-based scores predict patient survival by Bernhard Mlecnik, Gabriela Bindea, Marc Van den Eynde, Jérôme Galon

    Published 2020-01-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisions

    The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisions by Anastasia Lanzi, F. A. Sinicrope, A. B. Benson, Jérôme Galon

    Published 2020-01-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study

    No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study by Paolo A. Ascierto, Francesco M. Marincola, Bernard A. Fox, Jérôme Galon

    Published 2020-01-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    The Great Debate at ‘Immunotherapy Bridge’, Naples, December 5, 2019

    The Great Debate at ‘Immunotherapy Bridge’, Naples, December 5, 2019 by Jerome Galon, Chrystal M Paulos, Sergio A Quezada, Hussein A Tawbi

    Published 2020-07-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    743 High levels of stromal tumor infiltrating lymphocytes, CD3, CD8 cells & Immunoscore® are associated with pathological CR and time to progression in TNBC patients undergoing neo-adjuvant chemotherapy

    743 High levels of stromal tumor infiltrating lymphocytes, CD3, CD8 cells & Immunoscore® are associated with pathological CR and time to progression in TNBC patients undergoing neo... by Jerome Galon, Aurelie Fugon, Isabelle Boquet, Marine Martel, B Mlecnik, Farhana Moosa

    Published 2020-11-01
    Article
    Save to List
    Saved in:
  19. 19
    Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment

    Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment by Etienne D. Foucher, Clément Ghigo, Salem Chouaib, Salem Chouaib, Jérôme Galon, Juan Iovanna, Daniel Olive

    Published 2018-05-01
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    World-Wide Immunoscore Task Force: meeting report from the “Melanoma Bridge”, Napoli, November 30th–December 3rd, 2016

    World-Wide Immunoscore Task Force: meeting report from the “Melanoma Bridge”, Napoli, November 30th–December 3rd, 2016 by Jerome Galon, Alessandro Lugli, Carlo Bifulco, Franck Pages, Giuseppe Masucci, Francesco M. Marincola, Paolo A. Ascierto

    Published 2017-10-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: